Search Results

Clario, a leading provider of technologies and endpoint data solutions for clinical trials, announced the U.S. Food and Drug Administration 510 clearance for its SpiroSphere® with the wireless COR-12 Electrocardiogram device.

Clario, a healthcare research and technology company that delivers leading endpoint solutions for clinical trials, is pleased to announce a strategic partnership with Emsere, a trusted medical equipment supplier for clinical trials.

Cognizant announced it has been selected by Clario, a healthcare research technology company that delivers leading endpoint technology solutions for clinical trials, to support its global IT infrastructure and applications.

Clario today announced that the application of Opal® wearable sensor technology (legacy APDM, Inc.), with advisory from Precision Motion scientists, has helped the University of Oxford researchers develop a new understanding of motor symptom progression in Parkinson’s Disease, offering promising implications for neuroscience clinical trials and future treatments.

Clario today announced the appointment of a new Chief Financial Officer, Jason Knoblauch, and three internal promotions to the Executive Leadership Team.

Dr. Vince Clinical Research, an early phase Clinical Research Organization, announced a new collaboration with Clario, a leading healthcare research and technology company that delivers leading endpoint technology solutions for clinical trials.

Clario announced it is joining CancerX - a public-private partnership to act as a national accelerator to boost innovation in the fight against cancer.

Clario, a healthcare research technology company that delivers leading endpoint technology solutions for clinical trials, today announced an expansion to its collaboration with AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology.

Clario, a healthcare research technology company that delivers leading endpoint technology solutions for clinical trials, and the medical technology company Sleepiz AG announced today a strategic partnership to integrate novel sleep and respiratory parameters into clinical trials.

Clario and WeWork have partnered to provide Clario’s workforce with WeWork All Access passes and flexible space across the United States, United Kingdom, Germany, Belgium, Hungary, and Costa Rica, giving colleagues even more flexibility with where they work.